Citius Pharmaceuticals Inc
(FRA:47N)
€
0.3454
0.0234 (7.27%)
Market Cap: 75.77 Mil
Enterprise Value: 59.35 Mil
PE Ratio: 0
PB Ratio: 0.95
GF Score: 29/100 Citius Pharmaceuticals Inc CEORoadshow Interview with Leonard Mazur Transcript
Jul 10, 2020 / NTS GMT
Release Date Price:
€1.13
Mike Elliot
CEORoadshow - Moderator
Hi, I am Mike Elliot and you're watching CEORoadshow. Today we're joined by Mr. Leonard Mazur. He is the Chairman of Citius Pharmaceutics, a specialty pharmaceutical company focused on developing and commercializing critical care products. Their stock trades in the Nasdaq under CTXR.
Good morning, Leonard, and welcome to the show.
Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO & Chairman
Good morning, Mike, thank you for having me on, really appreciate it.
Questions & Answers
Mike Elliot
CEORoadshow - Moderator
Well, it's great to catch with you again.
And I guess to start off, just for investors new to the story, tell us how the company was founded.
Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-Founder, CEO & Chairman
All right. So, the history of the company is that the roots of it are with a private company that my partner, Myron Holubiak, who is the CEO, and I formed called
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot